| Income Statement |
| Operating Expenses | 2.25M |
|
| Research and Development Expense | 1.31M |
| Selling, General and Administrative Expense | 936.32K |
| Operating Income | -2.25M |
| Net Income | -2.22M |
| Net Income Common Stock | -2.22M |
| Net Income Common Stock (USD) | -2.22M |
| Consolidated Income | -2.22M |
| Earnings per Basic Share | -0.10 |
| Earnings per Basic Share (USD) | -0.10 |
| Earnings per Diluted Share | -0.10 |
| Earning Before Interest & Taxes (EBIT) | -2.22M |
| Earning Before Interest & Taxes (USD) | -2.22M |
| Weighted Average Shares | 22.25M |
| Weighted Average Shares Diluted | 22.25M |
| Balance Sheet |
| Cash and Equivalents | 2.79M |
| Cash and Equivalents (USD) | 2.79M |
| Current Assets | 3.16M |
| Property, Plant & Equipment Net | 6.40M |
| Total Assets | 9.87M |
| Current Liabilities | 1.19M |
| Total Liabilities | 1.19M |
| Accumulated Retained Earnings (Deficit) | -157.06M |
| Shareholders Equity | 8.68M |
| Shareholders Equity (USD) | 8.68M |
| Assets Non-Current | 6.71M |
| Goodwill and Intangible Assets | 309.80K |
| Trade and Non-Trade Payables | 1.15M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 129.75K |
| Net Cash Flow from Financing | 1.70M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -419.15K |
| Capital Expenditure | -1.00 |
| Issuance (Purchase) of Equity Shares | 1.70M |
| Net Cash Flow from Investing | -1.00 |
| Net Cash Flow from Operations | -2.12M |
| Share Based Compensation | -317.69K |